CytomX Therapeutics To Present Updated Preclinical Data For Conditionally Activated Cytokine Program At AACR Annual Meeting 2022
CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced that preclinical data supporting the ongoing development of its conditionally
68 Biggest Movers From Yesterday
Gainers
ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday.
41 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday.
CytomX Therapeutics Q4 EPS $(0.40) Misses $(0.28) Estimate, Sales $19.73M Miss $24.51M Estimate
CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.28) by 42.86 percent. This is a 29.03 percent decrease over losses of $(0.31) per share
HC Wainwright & Co. Maintains Buy on CytomX Therapeutics, Lowers Price Target to $11
HC Wainwright & Co. analyst Robert Burns maintains CytomX Therapeutics (NASDAQ:CTMX) with a Buy and lowers the price target from $12 to $11.
55 Biggest Movers From Yesterday
Gainers
Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday.